8-K filed July 7, 2021, 7:59 PM ET ticker PLSH CIK 0001552189

M&A confidence high sentiment neutral materiality 0.95

Exactus acquires Panacea Life Sciences; Leslie Buttorff becomes CEO

PANACEA LIFE SCIENCES HOLDINGS, INC.

Exactus issues 473.6M common shares + preferred stock to acquire Panacea; Buttorff owns ~61% fully diluted.
Leslie Buttorff named CEO/CFO with $380K salary plus $2.2M in shares upon NASDAQ listing.
22nd Century Group (XXII) receives 11.6% stake in combined company after exchanging Panacea preferred.
Board reduced to two directors; future additions include XXII CEO Jim Mish and Dr. Janice Nerger.
Reverse stock split 1-for-28 approved; company to rename as Panacea Life Sciences Holdings, Inc.

item 1.01 item 3.02 item 5.02 item 5.03 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John Price

director

PLSH · PANACEA LIFE SCIENCES HOLDINGS, INC.

Filed: July 7, 2021, 7:59 PM ET

John Price, a director (who had not held any officer positions with the Company), previously resigned from as a director of the Company.

Appointed

Leslie Buttorff

director

PLSH · PANACEA LIFE SCIENCES HOLDINGS, INC.

Effective: 2021-06-30
Filed: July 7, 2021, 7:59 PM ET

Leslie Buttorff was appointed director.

Role change

Mr. Wert

Executive Chairman

PLSH · PANACEA LIFE SCIENCES HOLDINGS, INC.

Filed: July 7, 2021, 7:59 PM ET

Mr. Wert previously was Executive Chairman but resigned from that role.

Departed

Julian Pittam

director

PLSH · PANACEA LIFE SCIENCES HOLDINGS, INC.

Effective: 2021-06-30
Filed: July 7, 2021, 7:59 PM ET

On June 30, 2021, Julian Pittam resigned as director of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

John Price resigned as director at PANACEA LIFE SCIENCES HOLDINGS, INC..

Action: resigned
Role: director

Exact text from the filing

John Price, a director (who had not held any officer positions with the Company), previously resigned from as a director of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Leslie Buttorff was appointed as director at PANACEA LIFE SCIENCES HOLDINGS, INC..

Action: appointed
Role: director

Exact text from the filing

Leslie Buttorff was appointed director.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.85

Mr. Wert resigned as Executive Chairman at PANACEA LIFE SCIENCES HOLDINGS, INC..

Action: resigned
Role: Executive Chairman

Exact text from the filing

Mr. Wert previously was Executive Chairman but resigned from that role.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Julian Pittam resigned as director at PANACEA LIFE SCIENCES HOLDINGS, INC..

Action: resigned
Role: director

Exact text from the filing

On June 30, 2021, Julian Pittam resigned as director of the Company

View on SEC.gov

PANACEA LIFE SCIENCES HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001654954-21-007695

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.